Franklin Resources
KZR

Franklin Resources’s Kezar Life Sciences KZR Stock Holding History

Franklin Resources’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-136,530
Closed -$1.62M – 2681
2023
Q3 		$1.62M Sell
136,530
-2,286
-2% -$40.5K ﹤0.01% 1454
2023
Q2 		$3.4M Buy
138,816
+2,274
+2% +$59.2K ﹤0.01% 1230
2023
Q1 		$4.27M Buy
136,542
+10
+0% +$579 ﹤0.01% 1128
2022
Q4 		$9.61M Hold
136,532
– – 0.01% 952
2022
Q3 		$11.8M Hold
136,532
– – 0.01% 892
2022
Q2 		$11.3M Sell
136,532
-112,075
-45% -$9.89M 0.01% 924
2022
Q1 		$41.3M Sell
248,607
-12
-0% -$1.72K 0.02% 651
2021
Q4 		$41.6M Buy
248,619
+20,784
+9% +$2.35M 0.02% 696
2021
Q3 		$19.7M Hold
227,835
– – 0.01% 901
2021
Q2 		$12.4M Buy
227,835
+25,140
+12% +$1.43M ﹤0.01% 975
2021
Q1 		$12.1M Hold
202,695
– – ﹤0.01% 934
2020
Q4 		$10.6M Buy
202,695
+5
+0% +$278 ﹤0.01% 953
2020
Q3 		$9.81M Hold
202,690
– – ﹤0.01% 909
2020
Q2 		$9.91M Hold
202,690
– – 0.01% 867
2020
Q1 		$8.84M Buy
202,690
+170,000
+520% +$6.92M 0.01% 829
2019
Q4 		$1.31M Hold
32,690
– – ﹤0.01% 1234
2019
Q3 		$1.07M Hold
32,690
– – ﹤0.01% 1260
2019
Q2 		$2.52M Sell
32,690
-760
-2% -$118K ﹤0.01% 1134
2019
Q1 		$5.93M Hold
33,450
– – ﹤0.01% 979
2018
Q4 		$7.89M Hold
33,450
– – ﹤0.01% 913
2018
Q3 		$7.16M Sell
33,450
-1,550
-4% -$271K ﹤0.01% 988
2018
Q2 		$6.05M Buy
+35,000
New +$6.11M ﹤0.01% 1014

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources's KZR Position: Q4 2023 in Review

Franklin Resources sold out of Kezar Life Sciences (KZR) in Q4 2023, closing a stake of 136,530 shares — an estimated $1.62M sold.

Franklin Resources first reported a position in KZR in Q2 2018 and held it in 22 quarters. The position peaked at $41.6M in Q4 2021. 81 funds tracked by Wall St. Rank hold KZR as of Q4 2023.

  • Franklin Resources reported no remaining Kezar Life Sciences position as of Q4 2023 after selling out during the quarter.
  • Franklin Resources sold 136,530 Kezar Life Sciences shares in Q4 2023, an estimated $1.62M.
  • Franklin Resources first reported a position in Kezar Life Sciences in Q2 2018 and held it in 22 quarters.
  • Franklin Resources's Kezar Life Sciences position peaked at $41.6M in Q4 2021.
  • 81 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q4 2023.

Based on Franklin Resources's 13F filing for Q4 2023, filed 9 Feb 2024.